IL1RAPL1 and neoplasm: In contrast, miR-34a-based therapies, such as MRX34, seek to re-establish tumor-suppressive signaling pathways by reinstating the expression of silenced miRNAs, ultimately inducing apoptosis and suppressing tumor growth [21,79,80,81,82,83,84,85].